vs
NewtekOne, Inc.（NEWT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
NewtekOne, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$73.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 111.8%，领先272.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -2.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 12.2%）
纽泰克是一家总部位于美国得克萨斯州圣安东尼奥的软硬件企业，专注于为个人电脑提供直播、后期制作视频工具及视觉成像软件。公司由蒂姆·杰尼森与保罗·蒙哥马利于1985年在美国堪萨斯州托皮卡创立，2019年4月宣布被Vizrt收购。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NEWT vs RIGL — 直观对比
营收规模更大
NEWT
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出23.9%
-2.7%
净利率更高
RIGL
高出272.2%
111.8%
两年增速更快
RIGL
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.3M | $69.8M |
| 净利润 | $19.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 111.8% | 384.0% |
| 营收同比 | -2.7% | 21.2% |
| 净利润同比 | 6.6% | 1769.2% |
| 每股收益（稀释后） | $0.64 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEWTRIGL
| Q4 25 | $73.3M | $69.8M | ||
| Q3 25 | $74.9M | $69.5M | ||
| Q2 25 | $70.2M | $101.7M | ||
| Q1 25 | $66.3M | $53.3M | ||
| Q4 24 | $75.4M | $57.6M | ||
| Q3 24 | $62.8M | $55.3M | ||
| Q2 24 | $61.1M | $36.8M | ||
| Q1 24 | $58.3M | $29.5M |
净利润NEWTRIGL
| Q4 25 | $19.5M | $268.1M | ||
| Q3 25 | $17.9M | $27.9M | ||
| Q2 25 | $13.7M | $59.6M | ||
| Q1 25 | $9.4M | $11.4M | ||
| Q4 24 | $18.3M | $14.3M | ||
| Q3 24 | $11.9M | $12.4M | ||
| Q2 24 | $10.9M | $-1.0M | ||
| Q1 24 | $9.7M | $-8.2M |
毛利率NEWTRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率NEWTRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率NEWTRIGL
| Q4 25 | 111.8% | 384.0% | ||
| Q3 25 | 23.9% | 40.2% | ||
| Q2 25 | 19.5% | 58.6% | ||
| Q1 25 | 14.1% | 21.5% | ||
| Q4 24 | 24.3% | 24.9% | ||
| Q3 24 | 19.0% | 22.5% | ||
| Q2 24 | 17.9% | -2.8% | ||
| Q1 24 | 16.6% | -27.9% |
每股收益（稀释后）NEWTRIGL
| Q4 25 | $0.64 | $14.11 | ||
| Q3 25 | $0.67 | $1.46 | ||
| Q2 25 | $0.52 | $3.28 | ||
| Q1 25 | $0.35 | $0.63 | ||
| Q4 24 | $0.70 | $0.82 | ||
| Q3 24 | $0.45 | $0.70 | ||
| Q2 24 | $0.43 | $-0.06 | ||
| Q1 24 | $0.38 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $819.9M | $52.5M |
| 股东权益账面价值 | $397.6M | $391.5M |
| 总资产 | $2.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 2.06× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NEWTRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务NEWTRIGL
| Q4 25 | $819.9M | $52.5M | ||
| Q3 25 | $748.5M | $60.0M | ||
| Q2 25 | $657.3M | $60.0M | ||
| Q1 25 | $774.0M | $60.0M | ||
| Q4 24 | $708.0M | $60.0M | ||
| Q3 24 | $655.8M | $60.0M | ||
| Q2 24 | $652.0M | $60.0M | ||
| Q1 24 | $662.5M | $60.0M |
股东权益NEWTRIGL
| Q4 25 | $397.6M | $391.5M | ||
| Q3 25 | $386.7M | $117.6M | ||
| Q2 25 | $312.2M | $81.9M | ||
| Q1 25 | $302.3M | $18.6M | ||
| Q4 24 | $296.3M | $3.3M | ||
| Q3 24 | $281.8M | $-14.6M | ||
| Q2 24 | $274.0M | $-29.9M | ||
| Q1 24 | $254.1M | $-31.7M |
总资产NEWTRIGL
| Q4 25 | $2.7B | $513.6M | ||
| Q3 25 | $2.4B | $242.5M | ||
| Q2 25 | $2.1B | $206.7M | ||
| Q1 25 | $2.1B | $176.0M | ||
| Q4 24 | $2.1B | $164.0M | ||
| Q3 24 | $1.7B | $139.4M | ||
| Q2 24 | $1.6B | $128.4M | ||
| Q1 24 | $1.5B | $126.5M |
负债/权益比NEWTRIGL
| Q4 25 | 2.06× | 0.13× | ||
| Q3 25 | 1.94× | 0.51× | ||
| Q2 25 | 2.11× | 0.73× | ||
| Q1 25 | 2.56× | 3.23× | ||
| Q4 24 | 2.39× | 18.25× | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 2.38× | — | ||
| Q1 24 | 2.61× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-579.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-579.3M | — |
| 自由现金流率自由现金流/营收 | -790.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | -29.64× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-1.0B | — |
8季度趋势，按日历期对齐
经营现金流NEWTRIGL
| Q4 25 | $-579.2M | $22.0M | ||
| Q3 25 | $-167.3M | $24.0M | ||
| Q2 25 | $-199.8M | $30.5M | ||
| Q1 25 | $-60.7M | $-893.0K | ||
| Q4 24 | $-153.0M | $14.5M | ||
| Q3 24 | $-25.7M | $21.7M | ||
| Q2 24 | $2.9M | $302.0K | ||
| Q1 24 | $-38.7M | $-5.0M |
自由现金流NEWTRIGL
| Q4 25 | $-579.3M | — | ||
| Q3 25 | $-167.3M | — | ||
| Q2 25 | $-199.9M | — | ||
| Q1 25 | $-60.7M | — | ||
| Q4 24 | $-153.5M | — | ||
| Q3 24 | $-25.9M | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $-38.7M | — |
自由现金流率NEWTRIGL
| Q4 25 | -790.0% | — | ||
| Q3 25 | -223.3% | — | ||
| Q2 25 | -284.7% | — | ||
| Q1 25 | -91.6% | — | ||
| Q4 24 | -203.6% | — | ||
| Q3 24 | -41.2% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | -66.5% | — |
资本支出强度NEWTRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率NEWTRIGL
| Q4 25 | -29.64× | 0.08× | ||
| Q3 25 | -9.35× | 0.86× | ||
| Q2 25 | -14.58× | 0.51× | ||
| Q1 25 | -6.48× | -0.08× | ||
| Q4 24 | -8.35× | 1.01× | ||
| Q3 24 | -2.15× | 1.75× | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | -4.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
